preeclampsia1920
Webinar

1st Trimester Pre-Eclampsia Screening – Is It Worth It?

These speeches aim to explore the value and implications of early pre-eclampsia screening during the first trimester of pregnancy. By assessing the benefits, risks, and cost-effectiveness, we’ll delve into real-life experiences and whether implementing such screening protocols is justified.

This live webinar was held May 2nd, 2024.

The esteemed panel of speakers includes:

  • Prof. Jon Hyett: “Pre-eclampsia 1st Trimester Screening: How it is Done and What is the Impact?” 
  • Prof. Dave Wright & Dr. Alan Wright: “Risk assessment and screening for preeclampsia”
  • Prof Jacques Jani: “Post-ASPRE era: Implementation of aspirin use among high-risk groups for pre-eclampsia”
     
To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Prof. Jon Hyett: “Pre-eclampsia 1st Trimester Screening: How it is Done and What is the Impact?”
 

jonhyett

Prof. Dave Wright & Dr. Alan Wright: “Risk assessment and screening for preeclampsia”
 

davewright

Prof Jacques Jani: “Post-ASPRE era: Implementation of aspirin use among high-risk groups for pre-eclampsia”
 

jacquesjani1


Revvity does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations please consult your local health care professionals.